天眼查App显示，近日，山东利龙昌新材料有限公司成立，法定代表人为王菲菲，注册资本300万人民 币，经营范围为一般项目：新材料技术推广服务；货物进出口；化工产品销售（不含许可类化工产 品）；食品添加剂销售；饲料添加剂销售；肥料销售；电池销售；石油制品销售（不含危险化学品）； 非金属矿及制品销售；润滑油销售；专用化学产品销售（不含危险化学品）；油墨销售（不含危险化学 品）；涂料销售（不含危险化学品）；化肥销售；合成材料销售；炼焦；选矿；石墨及碳素制品销售； 五金产品批发；建筑材料销售；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；技 术进出口。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

Core Insights - Zhengzhou Mingyao Biotechnology Co., Ltd. has been established with a registered capital of 50,000 RMB and is represented by Lin Kunming [1] Company Overview - The company operates in various sectors including technology services, development, consulting, and transfer [1] - It is involved in the sales of livestock and fishery feed, feed raw materials, feed additives, and pet food and supplies [1] - The company also engages in the sale of food additives, fertilizers, agricultural films, plastic products, disinfectants (excluding hazardous chemicals), daily chemicals, daily necessities, office supplies, stationery, and general merchandise [1]

Core Points - Lianyungang Yuno Food Co., Ltd. has been established with a registered capital of 100,000 RMB [1] - The legal representative of the company is Cui Jianan [1] - The business scope includes sales of food additives, health food (pre-packaged), feed additives, special chemical products (excluding hazardous chemicals), and chemical products (excluding licensed chemical products) [1] Business Scope - The company is involved in the sales of food additives and health food, indicating a focus on the food industry [1] - It also engages in the sale of feed additives and special chemical products, suggesting diversification into agricultural and chemical sectors [1] - The company offers various technical services, including development, consultation, and promotion, which may enhance its operational capabilities [1] - Internet sales of pre-packaged food and special medical purpose formula food are part of its business model, reflecting a modern approach to distribution [1]

天眼查App显示，近日，内蒙古实耀化工有限公司成立，法定代表人为韩广静，注册资本300万人民 币，经营范围为一般项目：化工产品生产（不含许可类化工产品）；化工产品销售（不含许可类化工产 品）；石油制品制造（不含危险化学品）；专用化学产品销售（不含危险化学品）；食品添加剂销售； 饲料添加剂销售；肥料销售；电池销售；生物基材料销售；新型催化材料及助剂销售；新材料技术研 发；工程和技术研究和试验发展；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广； 生物化工产品技术研发；金属包装容器及材料销售；塑料制品销售；五金产品零售；机械零件、零部件 销售；木制容器销售。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

Core Points - The articles outline the regulations and governance structure of Zhejiang Hisun Pharmaceutical Co., Ltd, emphasizing the protection of the rights of shareholders, employees, and creditors [1][3][4] - The company is established as a publicly listed joint-stock company with a registered capital of RMB 1,198.848196 million [2][7] - The company aims to be a leading pharmaceutical enterprise focusing on research and innovation, adhering to high production standards [5][6] Group 1: General Provisions - The company is established under the Company Law and other relevant regulations, with its legal representative being the chairman elected by the board [1][2] - The company has a permanent existence as a publicly listed joint-stock company [2] - The articles serve as a legally binding document governing the relationships and rights among the company, shareholders, and management [3][4] Group 2: Business Objectives and Scope - The company's business objective is to provide high-quality pharmaceutical products and health solutions globally, driven by research and innovation [5] - The business scope includes drug production, pharmaceutical wholesale, and various related activities, subject to legal approvals [5][6] Group 3: Shares - The company issues shares in the form of stocks, ensuring equal rights for all shares of the same category [7][8] - The total number of issued shares is 1,198,481,196, all of which are ordinary shares [7][8] - The company can provide financial assistance for acquiring its shares under specific conditions approved by the board [8][9] Group 4: Shareholder Rights and Meetings - Shareholders have rights to dividends, voting, and participation in company decisions, with equal rights for shares of the same category [14][15] - The company must hold annual and extraordinary shareholder meetings, with specific procedures for calling and conducting these meetings [48][49] - Shareholder proposals must be submitted within a specified timeframe before meetings, ensuring transparency and participation [58][59]

Core Points - Zhejiang Haizheng Pharmaceutical Co., Ltd. has completed the registration capital and business scope changes, and has obtained a new business license [1][2] - The changes were approved during the 35th meeting of the 9th Board of Directors on March 27, 2025, and at the annual shareholders' meeting on April 18, 2025 [1] - The updated business license includes a broader range of activities, including the production and sale of pharmaceutical excipients, veterinary drugs, cosmetics, health foods, and food additives [1] Summary by Category Company Changes - The company has successfully completed the business registration changes and the filing of the revised Articles of Association [1] - The new business license was issued by the Zhejiang Provincial Market Supervision Administration [1] Business Scope - The revised business scope now includes the production of traditional Chinese medicine, pharmaceutical excipients, veterinary drugs, cosmetics, health foods, and food additives [1] - The company is also authorized to engage in the wholesale of pharmaceuticals and the import and export of drugs [1] Additional Activities - The company can now conduct research and development in biological chemical products, provide technical services, and engage in various sales activities related to chemical products and health foods [1]